View in EDS

Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.

Saved in:
Bibliographic Details
Title: Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.
Authors: Gondry O; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be marleen.keyaerts@vub.be.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., Caveliers V; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., Xavier C; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Raes L; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., Vanhoeij M; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Verfaillie G; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Fontaine C; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Glorieus K; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., De Grève J; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Joris S; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Luyten I; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Zwaenepoel K; Centre for Oncological Research, University of Antwerp, Wilrijk, Belgium., Vandenbroucke F; Department of Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Waelput W; Department of Pathology, Universitair Ziekenhuis Brussel, Brussels, Belgium.; Experimental Pathology, Vrije Universiteit Brussel, Brussels, Belgium., Thyparambil S; mProbe, Rockville, Maryland; and., Vaneycken I; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., Cousaert J; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., Bourgeois S; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., Devoogdt N; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Goethals L; Department of Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Everaert H; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., De Geeter F; Department of Nuclear Medicine, Algemeen Ziekenhuis Sint-Jan Brugge Oostende, Bruges, Belgium., Lahoutte T; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium., Keyaerts M; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be marleen.keyaerts@vub.be.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Feb 01; Vol. 65 (2), pp. 178-184. Date of Electronic Publication: 2024 Feb 01.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38302159
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II Trial Assessing the Repeatability and Tumor Uptake of [<superscript>68</superscript>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gondry+O%22">Gondry O</searchLink>; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be marleen.keyaerts@vub.be.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Caveliers+V%22">Caveliers V</searchLink>; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Xavier+C%22">Xavier C</searchLink>; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Raes+L%22">Raes L</searchLink>; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Vanhoeij+M%22">Vanhoeij M</searchLink>; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Verfaillie+G%22">Verfaillie G</searchLink>; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Fontaine+C%22">Fontaine C</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Glorieus+K%22">Glorieus K</searchLink>; Department of Surgical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Grève+J%22">De Grève J</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Joris+S%22">Joris S</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Luyten+I%22">Luyten I</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Zwaenepoel+K%22">Zwaenepoel K</searchLink>; Centre for Oncological Research, University of Antwerp, Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Vandenbroucke+F%22">Vandenbroucke F</searchLink>; Department of Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Waelput+W%22">Waelput W</searchLink>; Department of Pathology, Universitair Ziekenhuis Brussel, Brussels, Belgium.; Experimental Pathology, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Thyparambil+S%22">Thyparambil S</searchLink>; mProbe, Rockville, Maryland; and.<br /><searchLink fieldCode="AU" term="%22Vaneycken+I%22">Vaneycken I</searchLink>; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Cousaert+J%22">Cousaert J</searchLink>; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Bourgeois+S%22">Bourgeois S</searchLink>; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Devoogdt+N%22">Devoogdt N</searchLink>; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Goethals+L%22">Goethals L</searchLink>; Department of Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Everaert+H%22">Everaert H</searchLink>; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Geeter+F%22">De Geeter F</searchLink>; Department of Nuclear Medicine, Algemeen Ziekenhuis Sint-Jan Brugge Oostende, Bruges, Belgium.<br /><searchLink fieldCode="AU" term="%22Lahoutte+T%22">Lahoutte T</searchLink>; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Keyaerts+M%22">Keyaerts M</searchLink>; Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be marleen.keyaerts@vub.be.; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2024 Feb 01; Vol. 65 (2), pp. 178-184. <i>Date of Electronic Publication: </i>2024 Feb 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38302159
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.123.266254
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 178
    Titles:
      – TitleFull: Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gondry O
      – PersonEntity:
          Name:
            NameFull: Caveliers V
      – PersonEntity:
          Name:
            NameFull: Xavier C
      – PersonEntity:
          Name:
            NameFull: Raes L
      – PersonEntity:
          Name:
            NameFull: Vanhoeij M
      – PersonEntity:
          Name:
            NameFull: Verfaillie G
      – PersonEntity:
          Name:
            NameFull: Fontaine C
      – PersonEntity:
          Name:
            NameFull: Glorieus K
      – PersonEntity:
          Name:
            NameFull: De Grève J
      – PersonEntity:
          Name:
            NameFull: Joris S
      – PersonEntity:
          Name:
            NameFull: Luyten I
      – PersonEntity:
          Name:
            NameFull: Zwaenepoel K
      – PersonEntity:
          Name:
            NameFull: Vandenbroucke F
      – PersonEntity:
          Name:
            NameFull: Waelput W
      – PersonEntity:
          Name:
            NameFull: Thyparambil S
      – PersonEntity:
          Name:
            NameFull: Vaneycken I
      – PersonEntity:
          Name:
            NameFull: Cousaert J
      – PersonEntity:
          Name:
            NameFull: Bourgeois S
      – PersonEntity:
          Name:
            NameFull: Devoogdt N
      – PersonEntity:
          Name:
            NameFull: Goethals L
      – PersonEntity:
          Name:
            NameFull: Everaert H
      – PersonEntity:
          Name:
            NameFull: De Geeter F
      – PersonEntity:
          Name:
            NameFull: Lahoutte T
      – PersonEntity:
          Name:
            NameFull: Keyaerts M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2024 Feb 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1